Coagulopathy after traumatic brain injury

Neurosurgery

Volumn 70, Issue 6, 2012, Pages 1334-1345

  Laroche, Mathieu ^a,b   Kutcher, Matthew E ^a   Huang, Michael C ^a,b   Cohen, Mitchell Jay ^a   Manley, Geoffrey T ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Coagulation; Coagulopathy; Head trauma; Secondary lesion; Traumatic brain injury

Indexed keywords

APROTININ; PLACEBO; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

ANTIGEN PRESENTING CELL; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; BRAIN DAMAGE; BRAIN HEMORRHAGE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; FIBRINOLYSIS; HEMOPHILIA; HUMAN; HYPERCOAGULABILITY; HYPOCOAGULABILITY; LABORATORY TEST; MICROTHROMBUS; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; THROMBOCYTE; THROMBOCYTE DYSFUNCTION; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY; TRAUMATIC BRAIN INJURY;

BLOOD COAGULATION DISORDERS; BRAIN INJURIES; HUMANS;

EID: 84861527489     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/NEU.0b013e31824d179b     Document Type: Review

References (135)

1. Harhangi BS, Kompanje EJ, Leebeek FW, Maas AI. Coagulation disorders after traumatic brain injury. Acta Neurochir (Wien). 2008;150(2):165-175; discussion 175.
2. Allard CB, Scarpelini S, Rhind SG, et al. Abnormal coagulation tests are associated with progression of traumatic intracranial hemorrhage. J Trauma. 2009;67(5):959-967.
3. Tian HL, Chen H, Wu BS, et al. D-Dimer as a predictor of progressive hemorrhagic injury in patients with traumatic brain injury: Analysis of 194 cases. Neurosurg Rev. 2010;33(3):359-365; discussion 365-366.
4. Oertel M, Kelly DF, McArthur D, et al. Progressive hemorrhage after head trauma: predictors and consequences of the evolving injury. J Neurosurg. 2002;96 (1):109-116.
5. Lustenberger T, Talving P, Kobayashi L, et al. Time course of coagulopathy in isolated severe traumatic brain injury. Injury. 2010;41(9):924-928.
6. Talving P, Benfield R, Hadjizacharia P, Inaba K, Chan LS, Demetriades D. Coagulopathy in severe traumatic brain injury: A prospective study. J Trauma. 2009;66(1):55-61; discussion 61-62.
7. Wafaisade A, Lefering R, Tjardes T, et al. Acute coagulopathy in isolated blunt traumatic brain injury. Neurocrit Care. 2010;12(2):211-219.
8. Vavilala MS, Dunbar PJ, Rivara FP, Lam AM. Coagulopathy predicts poor outcome following head injury in children less than 16 years of age. J Neurosurg Anesthesiol. 2001;13(1):13-18.
9. Piek J, Chesnut RM, Marshall LF, et al. Extracranial complications of severe head injury. J Neurosurg. 1992;77(6):901-907.
10. Stein SC, Young GS, Talucci RC, Greenbaum BH, Ross SE. Delayed brain injury after head trauma: significance of coagulopathy. Neurosurgery. 1992;30(2): 160-165.
11. Stein SC, Spettell C, Young G, Ross SE. Delayed and progressive brain injury in closed-head trauma: radiological demonstration. Neurosurgery. 1993;32(1): 25-30; discussion 30-31.
12. Stein SC, Smith DH. Coagulopathy in traumatic brain injury. Neurocrit Care. 2004;1(4):479-488.
13. van der Sande JJ, Emeis JJ, Lindeman J. Intravascular coagulation: A common phenomenon in minor experimental head injury. J Neurosurg. 1981;54(1): 21-25.
14. Kaufman HH, Hui KS, Mattson JC, et al. Clinicopathological correlations of disseminated intravascular coagulation in patients with head injury. Neurosurgery. 1984;15(1):34-42.
15. Cortez SC, McIntosh TK, Noble LJ. Experimental fluid percussion brain injury: vascular disruption and neuronal and glial alterations. Brain Res. 1989;482(2): 271-282.
16. Dietrich WD, Alonso O, Halley M. Early microvascular and neuronal consequences of traumatic brain injury: A light and electron microscopic study in rats. J Neurotrauma. 1994;11(3):289-301.
17. Dietrich WD, Alonso O, Busto R, et al. Widespread hemodynamic depression and focal platelet accumulation after fluid percussion brain injury: A doublelabel autoradiographic study in rats. J Cereb Blood Flow Metab. 1996;16(3): 481-489.
18. Maeda T, Katayama Y, Kawamata T, Aoyama N, Mori T. Hemodynamic depression and microthrombosis in the peripheral areas of cortical contusion in the rat: role of platelet activating factor. Acta Neurochir Suppl. 1997;70:102-105.
19. Scherer RU, Spangenberg P. Procoagulant activity in patients with isolated severe head trauma. Crit Care Med. 1998;26(1):149-156.
20. Astrup T. Assay and content of tissue thromboplastin in different organs. Thromb Diath Haemorrh. 1965;14(3-4):401-416.
21. Keimowitz RM, Annis BL. Disseminated intravascular coagulation associated with massive brain injury. J Neurosurg. 1973;39(2):178-180.
22. Goodnight SH, Kenoyer G, Rapaport SI, Patch MJ, Lee JA, Kurze T. Defibrination after brain-tissue destruction: A serious complication of head injury. N Engl J Med. 1974;290(19):1043-1047.
23. Fleck RA, Rao LV, Rapaport SI, Varki N. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb Res. 1990;59(2):421-437.
24. Gando S, Nanzaki S, Kemmotsu O. Coagulofibrinolytic changes after isolated head injury are not different from those in trauma patients without head injury. J Trauma. 1999;46(6):1070-1076; discussion 1076-1077.
25. Pathak A, Dutta S, Marwaha N, Singh D, Varma N, Mathuriya SN. Change in tissue thromboplastin content of brain following trauma. Neurol India. 2005;53 (2):178-182.
26. Halpern CH, Reilly PM, Turtz AR, Stein SC. Traumatic coagulopathy: the effect of brain injury. J Neurotrauma. 2008;25(8):997-1001.
27. Nemerson Y, Giesen PL. Some thoughts about localization and expression of tissue factor. Blood Coagul Fibrinolysis. 1998;9(suppl 1):S45-S47.
28. Hulka F, Mullins RJ, Frank EH. Blunt brain injury activates the coagulation process. Arch Surg. 1996;131(9):923-927; discussion 927-928.
29. Stein SC, Chen XH, Sinson GP, Smith DH. Intravascular coagulation: A major secondary insult in nonfatal traumatic brain injury. J Neurosurg. 2002;97(6): 1373-1377.
30. Carrick MM, Tyroch AH, Youens CA, Handley T. Subsequent development of thrombocytopenia and coagulopathy in moderate and severe head injury: support for serial laboratory examination. J Trauma. 2005;58(4):725-729; discussion 729-730.
31. Nekludov M, Bellander BM, Blomback M, Wallen HN. Platelet dysfunction in patients with severe traumatic brain injury. J Neurotrauma. 2007;24(11):1699- 1706.
32. Schnuriger B, Inaba K, Abdelsayed GA, et al. The impact of platelets on the progression of traumatic intracranial hemorrhage. J Trauma. 2010;68(4):881-885.
33. Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care. 2007;13(6):680-685.
34. Cohen MJ, Brohi K, Ganter MT, Manley GT, Mackersie RC, Pittet JF. Early coagulopathy after traumatic brain injury: the role of hypoperfusion and the protein C pathway. J Trauma. 2007;63(6):1254-1261; discussion 1261-1262.
35. Gerlach R, Krause M, Seifert V, Goerlinger K. Hemostatic and hemorrhagic problems in neurosurgical patients. Acta Neurochir (Wien). 2009;151(8):873-900; discussion 900.
36. Akins PT, Guppy KH, Sahrakar K, Hawk MW. Slippery platelet syndromes in subdural hematoma. Neurocrit Care. 2010;12(3):375-381.
37. Dickinson KJ, Troxler M, Homer-Vanniasinkam S. The surgical application of point-of-care haemostasis and platelet function testing. Br J Surg. 2008;95(11): 1317-1330.
38. Harle CC. Point-of-care platelet function testing. Semin Cardiothorac Vasc Anesth. 2007;11(4):247-251.
39. Jacoby RC, Owings JT, Holmes J, Battistella FD, Gosselin RC, Paglieroni TG. Platelet activation and function after trauma. J Trauma. 2001;51(4):639-647.
40. Jilma B. Platelet function analyzer (PFA-100): A tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med. 2001;138(3):152-163.
41. Weber AA, Adamzik M, Bachmann HS, et al. Methods to evaluate the pharmacology of oral antiplatelet drugs. Herz. 2008;33(4):287-296.
42. Luddington RJ. Thrombelastography/thromboelastometry. Clin Lab Haematol. 2005;27(2):81-90.
43. Gando S, Saitoh D, Ogura H, et al. Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients: results of a multicenter, prospective survey. Crit Care Med. 2008;36(1):145-150.
44. Brohi K, Cohen MJ, Ganter MT, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008;64(5):1211-1217; discussion 1217.
45. Schochl H, Frietsch T, Pavelka M, Jambor C. Hyperfibrinolysis after major trauma: differential diagnosis of lysis patterns and prognostic value of thrombelastometry. J Trauma. 2009;67(1):125-131.
46. Gonzalez E, Pieracci FM, Moore EE, Kashuk JL. Coagulation abnormalities in the trauma patient: the role of point-of-care thromboelastography. Semin Thromb Hemost. 2010;36(7):723-737.
47. Park MS, Martini WZ, Dubick MA, et al. Thromboelastography as a better indicator of hypercoagulable state after injury than prothrombin time or activated partial thromboplastin time. J Trauma. 2009;67(2):266-275; discussion 275-276.
48. Kashuk JL, Moore EE, Sabel A, et al. Rapid thrombelastography (r-TEG) identifies hypercoagulability and predicts thromboembolic events in surgical patients. Surgery. 2009;146(4):764-772; discussion 772-774.
49. Gonzalez E, Kashuk JL, Moore EE, Silliman CC. Differentiation of enzymatic from platelet hypercoagulability using the novel thrombelastography parameter delta (delta). J Surg Res. 2010;163(1):96-101.
50. Hartert H. Blutgerinnungsstudien mit der Thrombelastographie; einem neuen Untersuchungs verfahren (in German). KlinWochenschr. 1948;26(37-38):577-583.
51. Gorlinger K. Coagulation management during liver transplantation [in German]. Hamostaseologie. 2006;26(3 suppl 1):S64-S76.
52. Spalding GJ, Hartrumpf M, Sierig T, Oesberg N, Kirschke CG, Albes JM. Cost reduction of perioperative coagulation management in cardiac surgery: value of "bedside" thrombelastography (ROTEM). Eur J Cardiothorac Surg. 2007;31(6): 1052-1057.
53. Abrahams JM, Torchia MB, McGarvey M, Putt M, Baranov D, Sinson GP. Perioperative assessment of coagulability in neurosurgical patients using thromboelastography. Surg Neurol. 2002;58(1):5-11; discussion 11-12.
54. El Kady N, Khedr H, Yosry M, El Mekawi S. Perioperative assessment of coagulation in paediatric neurosurgical patients using thromboelastography. Eur J Anaesthesiol. 2009;26(4):293-297.
55. Kashuk JL, Moore EE, Sawyer M, et al. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg. 2010;252(3): 434-442; discussion 443-444.
56. Plotkin AJ, Wade CE, Jenkins DH, et al. A reduction in clot formation rate and strength assessed by thrombelastography is indicative of transfusion requirements in patients with penetrating injuries. J Trauma. 2008;64(2 suppl):S64-S68.
57. Kaur J, Jones N, Mallett S. Thrombelastography platelet mapping is a useful preoperative tool in surgical patients taking antiplatelet medication. Br J Anaesth. 2009;103(2):304; author reply 304-305.
58. Van PY, Cho SD, Underwood SJ, Morris MS, Watters JM, Schreiber MA. Thrombelastography versus anti-Factor Xa levels in the assessment of prophylactic-dose enoxaparin in critically ill patients. J Trauma. 2009;66(6):1509-1515; discussion 1515-1517.
59. Kashuk JL, Moore EE, Le T, et al. Noncitrated whole blood is optimal for evaluation of postinjury coagulopathy with point-of-care rapid thrombelastography. J Surg Res. 2009;156(1):133-138.
60. Dai Y, Lee A, Critchley LA, White PF. Does thromboelastography predict postoperative thromboembolic eventš A systematic review of the literature. Anesth Analg. 2009;108(3):734-742.
61. Drake TA, Morrissey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues: implications for disorders of hemostasis and thrombosis. Am J Pathol. 1989;134(5):1087-1097.
62. Eddleston M, de la Torre JC, Oldstone MB, Loskutoff DJ, Edgington TS, Mackman N. Astrocytes are the primary source of tissue factor in the murine central nervous system: A role for astrocytes in cerebral hemostasis. J Clin Invest. 1993;92(1):349-358.
63. Mackman N. Tissue-specific hemostasis: role of tissue factor. J Thromb Haemost. 2008;6(2):303-305.
64. Gando S, Nanzaki S, Morimoto Y, Kobayashi S, Kemmotsu O. Systemic activation of tissue-factor dependent coagulation pathway in evolving acute respiratory distress syndrome in patients with trauma and sepsis. J Trauma. 1999; 47(4):719-723.
65. Kearney TJ, Bentt L, Grode M, Lee S, Hiatt JR, Shabot MM. Coagulopathy and catecholamines in severe head injury. J Trauma. 1992;32(5):608-611; discussion 611-612.
66. Sawaya R, Kornblith PL. Brain tumors and thromboembolic complications. Surg Neurol. 1987;28(2):163.
67. Utter GH, Owings JT, Jacoby RC, Gosselin RC, Paglieroni TG. Injury induces increased monocyte expression of tissue factor: factors associated with head injury attenuate the injury-related monocyte expression of tissue factor. J Trauma. 2002; 52(6):1071-1077; discussion 1077.
68. Morel N, Morel O, Petit L, et al. Generation of procoagulant microparticles in cerebrospinal fluid and peripheral blood after traumatic brain injury. J Trauma. 2008;64(3):698-704.
69. Rijken DC, Wijngaards G, Welbergen J. Immunological characterization of plasminogen activator activities in human tissues and body fluids. J Lab ClinMed. 1981;97(4):477-486.
70. Kushimoto S, Shibata Y, Yamamoto Y. Implications of fibrinogenolysis in patients with closed head injury. J Neurotrauma. 2003;20(4):357-363.
71. Kushimoto S, Yamamoto Y, Shibata Y, Sato H, Koido Y. Implications of excessive fibrinolysis and alpha(2)-plasmin inhibitor deficiency in patients with severe head injury. Neurosurgery. 2001;49(5):1084-1089; discussion 1089-1090.
72. Drayer BP, Poser CM. Disseminated intravascular coagulation and head trauma: two case studies. JAMA. 1975;231(2):174-175.
73. MacGee EE, Bernell WR. Acute fibrinolysis following craniotomy and removal of metastatic tumor of the cerebellum: case report. J Neurosurg. 1970;32(5): 578-580.
74. Druskin MS, Drijansky R. Afibrinogenemia with severe head trauma. JAMA. 1972;219(6):755-756.
75. Vecht CJ, Sibinga CT, Minderhoud JM. Disseminated intravascular coagulation and head injury. J Neurol Neurosurg Psychiatry. 1975;38(6):567-571.
76. Goodnight SH Jr. Defibrination following head injury. Compr Ther. 1977;3(3): 25-28.
77. Auer L. Disturbances of the coagulatory system in patients with severe cerebral trauma. I. Acta Neurochir (Wien). 1978;43(1-2):51-59.
78. van der Sande JJ, Veltkamp JJ, Boekhout-Mussert RJ, Bouwhuis-Hoogerwerf ML. Head injury and coagulation disorders. J Neurosurg. 1978;49(3):357-365.
79. Auer LM, Ott E. Disturbances of the coagulatory system in patients with severe cerebral trauma, II: platelet function. Acta Neurochir (Wien). 1979;49(3-4): 219-226.
80. Touho H, Hirakawa K, Hino A, Karasawa J, Ohno Y. Relationship between abnormalities of coagulation and fibrinolysis and postoperative intracranial hemorrhage in head injury. Neurosurgery. 1986;19(4):523-531.
81. Crone KR, Lee KS, Kelly DL Jr. Correlation of admission fibrin degradation products with outcome and respiratory failure in patients with severe head injury. Neurosurgery. 1987;21(4):532-536.
82. Selladurai BM, Vickneswaran M, Duraisamy S, Atan M. Coagulopathy in acute head injury: A study of its role as a prognostic indicator. Br J Neurosurg. 1997;11 (5):398-404.
83. Cortiana M, Zagara G, Fava S, Seveso M. Coagulation abnormalities in patients with head injury. J Neurosurg Sci. 1986;30(3):133-138.
84. Vecht CJ, Minderhoud JM, Sibinga CT. Platelet aggregability in relation to impaired consciousness after head injury. J Clin Pathol. 1975;28(10):814-820.
85. Brohi K, Singh J, Heron M, Coats T. Acute traumatic coagulopathy. J Trauma. 2003;54(6):1127-1130.
86. Chesebro BB, Rahn P, Carles M, et al. Increase in activated protein C mediates acute traumatic coagulopathy in mice. Shock. 2009;32(6):659-665.
87. Knudson MM, Collins JA, Goodman SB, McCrory DW. Thromboembolism following multiple trauma. J Trauma. 1992;32(1):2-11.
88. Lustenberger T, Talving P, Kobayashi L, et al. Early coagulopathy after isolated severe traumatic brain injury: relationship with hypoperfusion challenged. J Trauma. 2010;69(6):1410-1414.
89. Bellander BM, Singhrao SK, Ohlsson M, Mattsson P, Svensson M. Complement activation in the human brain after traumatic head injury. J Neurotrauma. 2001; 18(12):1295-1311.
90. McKeating EG, Andrews PJ, Signorini DF, Mascia L. Transcranial cytokine gradients in patients requiring intensive care after acute brain injury. Br J Anaesth. 1997;78(5):520-523.
91. Minambres E, Cemborain A, Sanchez-Velasco P, et al. Correlation between transcranial interleukin-6 gradient and outcome in patients with acute brain injury. Crit Care Med. 2003;31(3):933-938.
92. Nekludov M, Antovic J, Bredbacka S, Blomback M. Coagulation abnormalities associated with severe isolated traumatic brain injury: cerebral arterio-venous differences in coagulation and inflammatory markers. J Neurotrauma. 2007;24 (1):174-180.
93. Olson JD, Kaufman HH, Moake J, et al. The incidence and significance of hemostatic abnormalities in patients with head injuries. Neurosurgery. 1989;24 (6):825-832.
94. Saggar V, Mittal RS, Vyas MC. Hemostatic abnormalities in patients with closed head injuries and their role in predicting early mortality. J Neurotrauma. 2009;26 (10):1665-1668.
95. Murray GD, Butcher I, McHugh GS, et al. Multivariable prognostic analysis in traumatic brain injury: results from the IMPACT study. J Neurotrauma. 2007;24 (2):329-337.
96. Chang EF, Meeker M, Holland MC. Acute traumatic intraparenchymal hemorrhage: risk factors for progression in the early post-injury period. Neurosurgery. 2006;58(4):647-656; discussion 647-656.
97. Stein SC, Graham DI, Chen XH, Smith DH. Association between intravascular microthrombosis and cerebral ischemia in traumatic brain injury. Neurosurgery. 2004;54(3):687-691; discussion 691.
98. Schwarzmaier SM, Kim SW, Trabold R, Plesnila N. Temporal profile of thrombogenesis in the cerebral microcirculation after traumatic brain injury in mice. J Neurotrauma. 2010;27(1):121-130.
99. Lu D, Mahmood A, Goussev A, Qu C, Zhang ZG, Chopp M. Delayed thrombosis after traumatic brain injury in rats. J Neurotrauma. 2004;21(12): 1756-1766.
100. Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation: British Committee for Standards in Haematology. Br J Haematol. 2009;145(1):24-33.
101. Kaufmann CR, Dwyer KM, Crews JD, Dols SJ, Trask AL. Usefulness of thrombelastography in assessment of trauma patient coagulation. J Trauma. 1997;42(4):716-720; discussion 720-722.
102. Ungerstedt JS, Grenander A, Bredbacka S, Blomback M. Clotting onset time may be a predictor of outcome in human brain injury: A pilot study. J Neurosurg Anesthesiol. 2003;15(1):13-18.
103. Peng HT. Thromboelastographic study of biomaterials. J Biomed Mater Res B Appl Biomater. 2010;94(2):469-485.
104. Kashuk JL, Moore EE, Sawyer M, et al. Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography. Ann Surg. 2010;251(4): 604-614.
105. Aguilar MI, Freeman WD. Treatment of coagulopathy in intracranial hemorrhage. Curr Treat Options Neurol. 2010;12(2):113-128.
106. Lucas CE, Ledgerwood AM, Saxe JM, Dombi G, Lucas WF. Plasma supplementation is beneficial for coagulation during severe hemorrhagic shock. Am J Surg. 1996;171(4):399-404.
107. Winter JP, Plummer D, Bottini A, Rockswold GR, Ray D. Early fresh frozen plasma prophylaxis of abnormal coagulation parameters in the severely headinjured patient is not effective. Ann Emerg Med. 1989;18(5):553-555.
108. Etemadrezaie H, Baharvahdat H, Shariati Z, Lari SM, Shakeri MT, Ganjeifar B. The effect of fresh frozen plasma in severe closed head injury. Clin Neurol Neurosurg. 2007;109(2):166-171.
109. Shakur H, Roberts R, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): A randomised, placebo-controlled trial. Lancet. 2010;376(9734):23-32.
110. Sorimachi T, Fujii Y, Morita K, Tanaka R. Rapid administration of antifibrinolytics and strict blood pressure control for intracerebral hemorrhage. Neurosurgery. 2005;57(5):837-844.
111. Palmer JD, Francis DA, Roath OS, Francis JL, Iannotti F. Hyperfibrinolysis during intracranial surgery: effect of high dose aprotinin. J Neurol Neurosurg Psychiatry. 1995;58(1):104-106.
112. Palmer JD, Francis JL, Pickard JD, Iannotti F. The efficacy and safety of aprotinin for hemostasis during intracranial surgery. J Neurosurg. 2003;98(6): 1208-1216.
113. Cravens GT, Brown MJ, Brown DR, Wass CT. Antifibrinolytic therapy use to mitigate blood loss during staged complex major spine surgery: postoperative visual color changes after tranexamic acid administration. Anesthesiology. 2006; 105(6):1274-1276.
114. Grady RE, Oliver WC Jr., Abel MD, Meyer FB. Aprotinin and deep hypothermic cardiopulmonary bypass with or without circulatory arrest for craniotomy. J Neurosurg Anesthesiol. 2002;14(2):137-140.
115. Mangano DT, Rieves RD, Weiss KD. Judging the safety of aprotinin. N Engl J Med. 2006;355(21):2261-2262.
116. Mangano DT, Tudor IC, Dietzel C. The risk associated with aprotinin in cardiac surgery. N Engl J Med. 2006;354(4):353-365.
117. Kessler CM. New perspectives in hemophilia treatment. Hematology Am Soc Hematol Educ Program. 2005:429-435.
118. Kenet G, Walden R, Eldad A, Martinowitz U. Treatment of traumatic bleeding with recombinant factor VIIa. Lancet. 1999;354(9193):1879.
119. Dutton RP, McCunn M, Hyder M, et al. Factor VIIa for correction of traumatic coagulopathy. J Trauma. 2004;57(4):708-718; discussion 718-719.
120. Narayan RK, Maas AI, Marshall LF, Servadei F, Skolnick BE, Tillinger MN. Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial. Neurosurgery. 2008;62(4):776-786;; discussion 786-788.
121. Roitberg B, Emechebe-Kennedy O, Amin-Hanjani S, Mucksavage J, Tesoro E. Human recombinant factor VII for emergency reversal of coagulopathy in neurosurgical patients: A retrospective comparative study. Neurosurgery. 2005;57 (5):832-836; discussion 832-836.
122. Bartal C, Freedman J, Bowman K, Cusimano M. Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa. J Trauma. 2007;63(4):725-732.
123. Brown CV, Foulkrod KH, Lopez D, et al. Recombinant factor VIIa for the correction of coagulopathy before emergent craniotomy in blunt trauma patients. J Trauma. 2010;68(2):348-352.
124. McQuay N Jr., Cipolla J, Franges EZ, Thompson GE. The use of recombinant activated factor VIIa in coagulopathic traumatic brain injuries requiring emergent craniotomy: is it beneficial? J Neurosurg. 2009;111(4):666-671.
125. Stein DM, Dutton RP, Kramer ME, Handley C, Scalea TM. Recombinant factor VIIa: decreasing time to intervention in coagulopathic patients with severe traumatic brain injury. J Trauma. 2008;64(3):620-627; discussion 627-628.
126. Stein DM, Dutton RP, Kramer ME, Scalea TM. Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma. J Trauma. 2009;66(1):63-72;; discussion 73-75.
127. Yusim Y, Perel A, Berkenstadt H, Attia M, Knoller N, Sidi A. The use of recombinant factor VIIa (NovoSeven) for treatment of active or impending bleeding in brain injury: broadening the indications. J Clin Anesth. 2006;18(7): 545-551.
128. Hoots WK. Experience with antithrombin concentrates in neurotrauma patients. Semin Thromb Hemost. 1997;23(suppl 1):3-16.
129. Owings JT, Gosselin R. Acquired antithrombin deficiency following severe traumatic injury: rationale for study of antithrombin supplementation. Semin Thromb Hemost. 1997;23(suppl 1):17-24.
130. Grenander A, Bredbacka S, Rydvall A, et al. Antithrombin treatment in patients with traumatic brain injury: A pilot study. J Neurosurg Anesthesiol. 2001; 13(1):49-56.
131. Bentzer P, Mattiasson G, McIntosh TK, Wieloch T, Grande PO. Infusion of prostacyclin following experimental brain injury in the rat reduces cortical lesion volume. J Neurotrauma. 2001;18(3):275-285.
132. Windelv NA, Welling KL, Ostrowski SR, Johansson PI. The prognostic value of thrombelastography in identifying neurosurgical patients with worse prognosis. Blood Coagul Fibrinolysis. 2011;22(5):416-419.
133. Tauber H, Innerhofer P, Breitkopf R, et al. Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the "Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study." Br J Anaesth. 2011;107(3):378-387.
134. Stein SC, Ganguly K, Belfield CM, et al. Erythrocyte-bound tissue plasminogen activator is neuroprotective in experimental traumatic brain injury. J Neurotrauma. 2009;26(9):1585-1592.
135. Danielyan K, Ganguly K, Ding BS, et al. Cerebrovascular thromboprophylaxis in mice by erythrocyte-coupled tissue-type plasminogen activator. Circulation. 2008;118(14):1442-1449